Streetbeat News

Earnings

APTV

DAL

UBER

Delta Air Lines, Uber Technologies, and Aptiv were featured on CNBC's 'Final Trades'. Delta is expected to report strong quarterly earnings with an increase in EPS and revenue. Uber's price target was raised by Wells Fargo, and Aptiv is anticipated to report higher earnings and revenue for its first quarter. Delta and Aptiv's stock prices increased, while Uber's decreased in the last trading session.

Portfolio Pulse from Avi Kapoor

April 09, 2024 | 12:59 pm

NAOV

NanoVibronix reported its Q4 2023 revenue to be approximately $1.2 million.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:56 pm

NAOV

NanoVibronix has issued a letter to its stockholders, emphasizing its commitment to developing and commercializing its therapies. The company highlights positive results in recent quarterly financials, high patient satisfaction with its products, and no adverse events. It is investing in sales improvement and long-term opportunities.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:55 pm

TAOP

Taoping Inc. reported an estimated Q1 2024 contract revenue of approximately $8.3 million, marking a 53% increase compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:54 pm

PSMT

PriceSmart, Inc. (NASDAQ:PSMT) is expected to release its Q2 earnings on April 9, 2024, with analysts projecting an earnings increase to $1.25 per share from $1.02 the previous year, and revenue of $1.28 billion. The company recently raised its annual dividend to $1.16 per share, yielding 1.39%. To earn a $500 monthly dividend income, an investor would need to own approximately 5,172 shares, valued around $432,017. The article also explains how dividend yield changes with stock price and dividend payment adjustments. PSMT's stock rose 0.7% to close at $83.53 recently.

Portfolio Pulse from Avi Kapoor

April 09, 2024 | 12:53 pm

BCTX

BriaCell presented positive Phase 2 data for Bria-IMT™, showing promising results in ADC resistant and CNS metastatic breast cancer at AACR 2024. The data revealed a PFS of 4.2 months, double that of controls, and a clinical benefit rate of 56%. The findings also highlighted a 71% intracranial objective response rate in heavily pretreated patients, underscoring Bria-IMT™'s potential in advanced breast cancer treatment. Additionally, preclinical data for Bria-OTS+™ and Bria-PROS+™ will be presented, indicating ongoing research efforts.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:49 pm

ASX

ASE Technology's shares saw an increase following the announcement of their financial results for March.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:46 pm

AMIX

Autonomix has announced results from a preclinical study indicating that its technology could enhance the safety and effectiveness of renal denervation, a procedure used to treat hypertension. The study's findings support the ongoing development of Autonomix's sensing and ablation technologies, which are moving towards a proof-of-concept clinical study.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:46 pm

NSC

Norfolk Southern's shares dropped following the announcement of preliminary Q1 results, which include a $600 million agreement to settle a class action lawsuit related to the East Palestine derailment.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:45 pm

NSC

Norfolk Southern reported preliminary Q1 adjusted earnings per share (EPS) of $2.49, falling short of the estimated $2.61. The railway operating revenues were reported at $3.004 billion.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:43 pm